NexPlasmaGen

Montreal, Canada · Founded 2008 · Privately Held (backing)

Developer of cold plasma delivery system designed to reduce cancer recurrence. NexPlasmaGen is based in Montreal, Canada and was founded in 2008. Its last reported valuation was $6.6 million in Dec 2024. It has raised $960,000.

Last reported valuation
$6.6M
Oct 2026
Priced at
—
Total raised
$960K
Last round
—

Who backs NexPlasmaGen?

25 investors
InvestorType
Government of QuebecOther
Kettlebeck VenturesFamily office
Aligo Innovation—
Andy Ortaaslan—
Campus des technologies de la santé—
Centre Québécois d'Innovation en Biotechnologie—
David Rowley—
Florent Chandelier—
Frederic Francis—
IRAP—
+ 15 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

NexPlasmaGen investors

25 investors are on record for NexPlasmaGen, including Government of Quebec, Kettlebeck Ventures, Aligo Innovation and Andy Ortaaslan.

Free account
More of NexPlasmaGen with a free account
  • ·The complete investor list: 25 names
  • ·Watch NexPlasmaGen: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 25 firms already write checks for companies like NexPlasmaGen. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View